Bullish
Neurocrine Biosciences presented the first retrospective case series on CRENENSITY for classic congenital adrenal hyperplasia (CAH) due to 11β‑hydroxy...
Bullish
Neurocrine Biosciences (NBIX) recently released new data from its KINECT 4 trial and real-world findings for INGREZZA, showing clinically meaningful r...
Neurocrine Biosciences (NBIX) is gaining attention due to new CRENESSITY crinecerfont data and strong stock performance, with investors reassessing it...
Neutral
Suncoast Equity Management purchased a new stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) during the fourth quarter, acco...